HHealth Read More GLP-1s Cut CV Risks Tied to Type 2 Diabetes and ADAugust 22, 2025 TOPLINE: GLP-1 receptor agonists (RAs) cut cardiovascular risks among patients with type 2 diabetes (T2D) and atopic dermatitis…